Cellectar Biosciences Inc... (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.27

0.01 (2.20%)

At close: May 02, 2025, 3:59 PM

0.27

-0.04%

After-hours: May 02, 2025, 05:05 PM EDT

Cellectar Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	192.38K	238.87K	227.64K	207.93K	189.36K	82.27K	1.55M	356.67K
Gross Profit	n/a	-192.38K	-238.87K	-227.64K	-207.93K	-189.36K	-82.27K	-1.55M	-356.67K
Operating Income	-51.78M	-38.96M	-28.81M	-24.13M	-15.29M	-14.18M	-13.33M	-13.6M	-9.45M
Interest Income	1.21M	n/a	152.52K	2.28K	10.9K	42.71K	n/a	n/a	n/a
Pretax Income	-44.52M	-38.04M	-28.66M	-24.12M	-15.09M	-14.09M	-13.24M	-13.56M	-6.18M
Net Income	-44.58M	-37.98M	-28.6M	-23.97M	-14.76M	-13.87M	-13.24M	-13.56M	-6.18M
Selling & General & Admin	25.64M	11.69M	9.59M	6.54M	5.15M	5.18M	4.82M	4.14M	4.7M
Research & Development	26.14M	27.27M	19.22M	17.59M	10.14M	9M	6.84M	9.47M	4.75M
Other Expenses	n/a	-0.00	n/a	6.63K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	51.78M	38.96M	28.81M	24.13M	15.29M	14.18M	11.66M	13.6M	9.45M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	29.69K	16.61K	7.9K
Selling & Marketing Expenses	n/a	945.18K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	38.96M	28.81M	24.13M	15.29M	14.18M	11.66M	13.6M	9.45M
Income Tax Expense	66K	-60K	-60K	-152.2K	-337.63K	-218.51K	-1.55M	-38.68K	-3.27M
Shares Outstanding (Basic)	36.62M	12.22M	7.06M	5.55M	1.98M	767.51K	296.2K	140.31K	43.67K
Shares Outstanding (Diluted)	37.14M	12.22M	7.06M	5.55M	1.98M	767.51K	296.2K	140.31K	43.67K
EPS (Basic)	-1.22	-3.11	-4.05	-4.32	-7.45	-18.08	-44.7	-96.66	-141.54
EPS (Diluted)	-1.2	-3.11	-4.05	-4.32	-7.45	-18.08	-44.7	-96.66	-141.54
EBITDA	-44.22M	-38.77M	-28.67M	-23.98M	-15.15M	-13.9M	-13.16M	-12.05M	-9.09M
EBIT	n/a	-38.96M	-28.81M	-24.12M	-15.29M	-14.09M	-13.24M	-13.6M	-9.45M
Depreciation & Amortization	n/a	192.38K	238.87K	227.64K	207.93K	189.36K	82.27K	1.55M	356.67K